Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Topiramate NDC 70934-450 by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
022dc727 c077 4611 8a3d 967ee99f9828 01
022dc727 c077 4611 8a3d 967ee99f9828 02
This is a graph displaying the cumulative rates for the time to the first seizure for patients taking Topiramate at a dosage of 50mg/day (N=234) and 400mg/day (N=236). The x-axis shows the time in days and the y-axis shows the cumulative rates. There is no further information available.*
022dc727 c077 4611 8a3d 967ee99f9828 03
During the Double-Blind Phase, there was a significant decrease in the average monthly migraine period rate of 56% compared to the baseline. This change was observed in patients taking both 100 and 200 milligrams of Topamax per day. The results are statistically significant with *p<0.010 and **p<0.001.*
70934 450 30 Master Bottle Label Approval Rev A 10 19
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.